Home > News > featured news > Orion Health strengthens North American operations with new technology and leadership

DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS

Orion Health strengthens North American operations with new technology and leadership

prnewswire | March 27, 2023 | Read time : 02:00 min

Orion Health strengthens North American

Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of James Rice as Executive Vice President for North America.

With operations in 12 U.S States and seven Canadian Provinces, the company has long been at the forefront of transformational Digital Health in North America. Orion Health is continuing on this path with the launch of the Amadeus Unified Healthcare Platform leading away from traditional broken healthcare systems, by creating patient-first digital health solutions.

Alongside his new position, Rice will continue in his strategic role on the Orion Health global Executive Leadership Team with responsibility for the company's sales, business growth and marketing strategy. His new role will see Orion Health having a global executive on the ground in North America and demonstrates the company's confidence and commitment to this significant market.

Brad Porter, Orion Health Global Chief Executive says the North American health sector is in desperate need for innovative technology to reduce the strain brought on by the pandemic and the ever-increasing shortage of medical professionals.

"To overcome the challenges facing the sector today, we need to reimagine how IT can improve healthcare by giving more time back to medical professionals and making health systems easier for users to navigate. We're already seeing how Digital Front Door technology is achieving this in parts of Canada, and we look forward to introducing these solutions across more regions in North America," says Porter.

Orion Health has been operating in North America for more than 25 years. In addition to its DFD, Orion Health has developed over 30 state or province-wide Digital Care Records (DCR) or health information exchanges across the US and Canada, allowing health information to flow seamlessly to and from authorized organizations and individuals across the state.

Amadeus Unified Healthcare Platform

In 2023 Orion Health is reinventing its Amadeus Unified Healthcare Platform, which is made up of its Digital Care Record (DCR), Digital Front Door (DFD), and its new Health Intelligence Platform (HIP).

"HIP is an exciting new health-centric solution that helps customers get the most out of their data. As a core component of the Amadeus Unified Healthcare Platform, HIP is a scalable, modular data solution that compliments the full range of products in the Amadeus suite.

"James will lead the implementation of Orion Health's Amadeus Unified Healthcare Platform strategy across North America, and thus will play an instrumental role in improving health outcomes for the region," says Porter.

In his new role, Rice is leading the North American arm of Orion Health as well as the Middle East. He is responsible for creating and leading revenue streams focused on these markets.

With more than 25 years of experience, five of which at Orion Health, James's experience makes him the perfect candidate to lead the team working to deliver the right care, to the right people, at the right time.

"The North American market is hugely important to Orion Health. I'm looking forward to engaging with existing and prospective customers, showing them how our transformational new technology will change the game for healthcare," says Rice.

About Orion Health

Orion Health is a global healthcare technology company focused on reimagining healthcare for all. We are leading the change in digital health with health and care organizations to improve the wellbeing of every individual with our world leading Unified Healthcare Platform. Made up of a Digital Front Door, Digital Care Record, and Intelligence Platform - each underpinned by extensive health and social data sets, machine learning, and 30 years of innovation focused purely on improving global well-being.

Spotlight

Omni Interactions Partners with Carbon Health to Provide Nearshore Urgent Care Patient Support

Watch how Omni Interactions saved Carbon Health 35-55% on customer support costs while maintaining excellent healthcare services.

More featured news

Spotlight

Omni Interactions Partners with Carbon Health to Provide Nearshore Urgent Care Patient Support

Watch how Omni Interactions saved Carbon Health 35-55% on customer support costs while maintaining excellent healthcare services.

Related News

HEALTHCARE ANALYTICS

Kaiser Permanente Announces New Grant Program for Artificial Intelligence and Machine Learning in Health Care

PRNewswire | May 18, 2023

The Permanente Medical Group announced the launch of the Kaiser Permanente Northern California Division of Research (KP-DOR) Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center. The new program will lead a national research effort focused on evaluating the implementation of artificial intelligence (AI) and machine learning (ML) algorithms to enhance diagnostic decision-making in health care. With support from the Gordon and Betty Moore Foundation, AIM-HI will award grants of up to $750,000 for three to five U.S. health care systems to support the use of AI and ML to improve diagnoses and patient outcomes. AI and ML have shown promise in early warning systems that analyze hospital patients' data to identify when patients are at risk of serious decline and may need intervention; large language models similar to ChatGPT that streamline medical record notetaking; and computer vision technology to analyze medical images for tumors, cancers and surgical guidance. "We're aiming to cut through the buzz around AI in health care to prove the promise and positive impact of this exciting technology for improving patient outcomes," said Vincent Liu, MD, principal investigator of AIM-HI. "In addition to supporting algorithmic research, the AIM-HI program will develop best practices, and improve the capacity for AI/ML deployment in diverse health care settings. It's vital that we use these powerful tools thoughtfully and in a way that scales to benefit patients, physicians and care teams." The request for proposals is now open and letters of intent are due June 30, 2023. A national advisory committee and expert reviewers from Kaiser Permanente will assess proposals and work closely with the selected project teams during their 2-year grant period. "At Kaiser Permanente, we've demonstrated the real-world benefits of AI and ML with groundbreaking algorithms," said Stephen Parodi, MD, executive vice president of The Permanente Federation. "Our early warning systems are at work 24 hours a day, 7 days a week to identify high-risk hospitalized patients. One of these programs has saved an estimated 500 lives a year. With this initiative we hope to support the spread of impactful work in health systems of all sizes across the country." About The Permanente Federation The Permanente Federation LLC is the national leadership and consulting organization for the 8 Permanente Medical Groups, which, together with the Kaiser Foundation Health Plans and Kaiser Foundation Hospitals, comprise Kaiser Permanente. The Federation works on behalf of the Permanente Medical Groups to optimize care delivery and spread Permanente Medicine — care that is person- and family-centered, compassionate, evidence-based, technology-enabled, culturally responsive, team-delivered, and physician-led. The Federation, based in Oakland, California, fosters an open learning environment and accelerates research, innovation, and performance improvements across the Permanente Medical Groups to expand the reach of Kaiser Permanente's integrated care delivery model and to lead the nation in transforming health care delivery.

Read More

HEALTHCARE ANALYTICS

Aspirion Announces Acquisition of FIRM Revenue Cycle Management Services, Inc.

PRNewswire | May 22, 2023

Aspirion, a leading technology-enabled healthcare revenue cycle management ("RCM") provider for complex claims and revenue integrity, announced today that it has acquired FIRM Revenue Cycle Management Services, Inc. ("FIRM RCM"), a trusted partner to hospital systems in the recovery of denied, unpaid, and underpaid medical insurance claims. As part of the announcement, the FIRM RCM team will continue to be led by Nancy Momcilovic. Simultaneously, Joseph Cook, Principal, will retire from active management following the completion of the acquisition. The acquisition closed on May 18, 2023. "We are thrilled to welcome FIRM RCM to the Aspirion family," said Amy Amick, CEO of Aspirion. "FIRM RCM has been built upon an incredible commitment to client excellence and robust subject matter expertise which is the backbone for the exceptional value they bring to their clients. This core fiber to the company's DNA aligns extremely well with Aspirion's. We know together we can help bring even greater value to the market." "FIRM RCM is excited to join forces with Aspirion," said Nancy Momcilovic, Esq. President of FIRM RCM. "Aspirion's expertise and reputation in revenue cycle management are unparalleled, and we believe that together, we can create even more value for our healthcare clients. We carefully selected Aspirion to partner with given our aligned values and culture, and the shared strength of our teams. We are excited to be able to leverage their advanced technologies over time to bring even greater value to our clients." "The combination of Aspirion and FIRM RCM demonstrates Aspirion's commitment to investing in high-growth companies positioned to address the increasingly complex financial challenges of the US healthcare system," said Richard Thomas, Chairman of the Board of Aspirion. This acquisition marks Aspirion's sixth successful transaction in the past five years, further bolstering the range of services available to its clients. In addition to its mergers, acquisitions, and strategic partnerships, Aspirion maintains a strong record of client retention, expanding services within existing clients, and acquiring new clients, all of which underscore the significant value Aspirion brings to the healthcare market. About Aspirion Aspirion, headquartered in Columbus, Ga., helps hospitals and physicians recover otherwise lost claims revenue via overturning denials and underpayments, resolving aged AR, and effectively collecting complex claims including motor vehicle accident, workers' compensation, Veterans Affairs and TRICARE, and out-of-state Medicaid. Aspirion's experienced team of healthcare, legal, and technical professionals combined with industry-leading technology platforms help ensure providers receive their Complex RCM revenue so that they can focus on patient care. The Company serves clients across the United States, including half of the ten largest health systems in the country.

Read More

MEDICAL DEVICES, HEALTHCARE ANALYTICS

Stanford Spinoff PhysioWave Announces Clinical Study with Omron Healthcare

PRNewswire | May 05, 2023

PhysioWave, a spinoff from Stanford University, successfully completed a 200-subject clinical study with OMRON Healthcare Co., Ltd., a global leader in medical devices for health monitoring and treatment. PhysioWave has been developing rapid, non-invasive technology to measure a person's risk of cardiovascular disease, using a weight scale, when they arrive for a clinic visit. PhysioWave's technology is mature and FDA-cleared, and PhysioWave is seeking opportunities to bring this important new technology to the consumer space through partnerships. The PhysioWave Pro™ scale measures the stiffness of the major blood vessel into which the heart pumps, the aorta. Stiffness increases with age, but excess stiffness among people of similar ages can be a warning sign of risk. It is established that increased vascular stiffness can predict the later development of high blood pressure, or hypertension, and a higher risk of cardiovascular disease. "The chance to work with OMRON Healthcare is a true honor. We have used their blood pressure instruments as reference standards on many clinical studies and greatly value their brand power," said PhysioWave founder, Greg Kovacs, MD, PhD. The study was carried out in Kyoto, Japan, and was intended to explore the use of PhysioWave's technology to assess cardiovascular disease risk at home. This new technology could be used to monitor the beneficial effects of lifestyle changes or prescription medicines for preventing and managing cardiovascular disease. It is widely recognized that cardiovascular diseases are the leading cause of death globally, and the PhysioWave vascular stiffness technology is low-cost and requires no disposables to deliver meaningful information in under one minute. The study validated the accuracy and reproducibility of PhysioWave's vascular stiffness technology in a wide distribution of subject attributes such as age and BMI. "As we move more aggressively into disease prevention, rather than treating cardiovascular disease after it has manifested, the ability to carry out personalized cardiovascular risk assessment assumes even greater importance to our healthcare systems" said Judith Swain, MD, PhysioWave CMO, and previous Chair of Medicine at Stanford and previous Chief of Cardiovascular Medicine at the University of Pennsylvania. "OMRON Healthcare is exploring innovative technologies to help prevention and management of cardiovascular diseases for its "Going for ZERO" vision, including collaboration with partners. The accuracy of PhysioWave's vascular stiffness technology was excellent. We look forward to further exploration of cardiovascular measurement technology at home with this collaboration," said Minoru Yoshimura, Executive Officer, OMRON Healthcare Co., Ltd. PhysioWave and OMRON intend to continue to explore opportunities for vascular stiffness in consumer settings, including its use to help identify persons with a higher risk of cardiovascular disease and to provide feedback as they manage their conditions. About OMRON Healthcare Committed to advance health and empower people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision "Going for ZERO, Preventive Care for the Health of Society", the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients to reduce cerebro-cardiovascular events, aggravation of respiratory diseases and restrictions due to chronic pain. With well over 300 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions and provides products and services in over 110 countries.

Read More

HEALTHCARE ANALYTICS

Kaiser Permanente Announces New Grant Program for Artificial Intelligence and Machine Learning in Health Care

PRNewswire | May 18, 2023

The Permanente Medical Group announced the launch of the Kaiser Permanente Northern California Division of Research (KP-DOR) Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center. The new program will lead a national research effort focused on evaluating the implementation of artificial intelligence (AI) and machine learning (ML) algorithms to enhance diagnostic decision-making in health care. With support from the Gordon and Betty Moore Foundation, AIM-HI will award grants of up to $750,000 for three to five U.S. health care systems to support the use of AI and ML to improve diagnoses and patient outcomes. AI and ML have shown promise in early warning systems that analyze hospital patients' data to identify when patients are at risk of serious decline and may need intervention; large language models similar to ChatGPT that streamline medical record notetaking; and computer vision technology to analyze medical images for tumors, cancers and surgical guidance. "We're aiming to cut through the buzz around AI in health care to prove the promise and positive impact of this exciting technology for improving patient outcomes," said Vincent Liu, MD, principal investigator of AIM-HI. "In addition to supporting algorithmic research, the AIM-HI program will develop best practices, and improve the capacity for AI/ML deployment in diverse health care settings. It's vital that we use these powerful tools thoughtfully and in a way that scales to benefit patients, physicians and care teams." The request for proposals is now open and letters of intent are due June 30, 2023. A national advisory committee and expert reviewers from Kaiser Permanente will assess proposals and work closely with the selected project teams during their 2-year grant period. "At Kaiser Permanente, we've demonstrated the real-world benefits of AI and ML with groundbreaking algorithms," said Stephen Parodi, MD, executive vice president of The Permanente Federation. "Our early warning systems are at work 24 hours a day, 7 days a week to identify high-risk hospitalized patients. One of these programs has saved an estimated 500 lives a year. With this initiative we hope to support the spread of impactful work in health systems of all sizes across the country." About The Permanente Federation The Permanente Federation LLC is the national leadership and consulting organization for the 8 Permanente Medical Groups, which, together with the Kaiser Foundation Health Plans and Kaiser Foundation Hospitals, comprise Kaiser Permanente. The Federation works on behalf of the Permanente Medical Groups to optimize care delivery and spread Permanente Medicine — care that is person- and family-centered, compassionate, evidence-based, technology-enabled, culturally responsive, team-delivered, and physician-led. The Federation, based in Oakland, California, fosters an open learning environment and accelerates research, innovation, and performance improvements across the Permanente Medical Groups to expand the reach of Kaiser Permanente's integrated care delivery model and to lead the nation in transforming health care delivery.

Read More

HEALTHCARE ANALYTICS

Aspirion Announces Acquisition of FIRM Revenue Cycle Management Services, Inc.

PRNewswire | May 22, 2023

Aspirion, a leading technology-enabled healthcare revenue cycle management ("RCM") provider for complex claims and revenue integrity, announced today that it has acquired FIRM Revenue Cycle Management Services, Inc. ("FIRM RCM"), a trusted partner to hospital systems in the recovery of denied, unpaid, and underpaid medical insurance claims. As part of the announcement, the FIRM RCM team will continue to be led by Nancy Momcilovic. Simultaneously, Joseph Cook, Principal, will retire from active management following the completion of the acquisition. The acquisition closed on May 18, 2023. "We are thrilled to welcome FIRM RCM to the Aspirion family," said Amy Amick, CEO of Aspirion. "FIRM RCM has been built upon an incredible commitment to client excellence and robust subject matter expertise which is the backbone for the exceptional value they bring to their clients. This core fiber to the company's DNA aligns extremely well with Aspirion's. We know together we can help bring even greater value to the market." "FIRM RCM is excited to join forces with Aspirion," said Nancy Momcilovic, Esq. President of FIRM RCM. "Aspirion's expertise and reputation in revenue cycle management are unparalleled, and we believe that together, we can create even more value for our healthcare clients. We carefully selected Aspirion to partner with given our aligned values and culture, and the shared strength of our teams. We are excited to be able to leverage their advanced technologies over time to bring even greater value to our clients." "The combination of Aspirion and FIRM RCM demonstrates Aspirion's commitment to investing in high-growth companies positioned to address the increasingly complex financial challenges of the US healthcare system," said Richard Thomas, Chairman of the Board of Aspirion. This acquisition marks Aspirion's sixth successful transaction in the past five years, further bolstering the range of services available to its clients. In addition to its mergers, acquisitions, and strategic partnerships, Aspirion maintains a strong record of client retention, expanding services within existing clients, and acquiring new clients, all of which underscore the significant value Aspirion brings to the healthcare market. About Aspirion Aspirion, headquartered in Columbus, Ga., helps hospitals and physicians recover otherwise lost claims revenue via overturning denials and underpayments, resolving aged AR, and effectively collecting complex claims including motor vehicle accident, workers' compensation, Veterans Affairs and TRICARE, and out-of-state Medicaid. Aspirion's experienced team of healthcare, legal, and technical professionals combined with industry-leading technology platforms help ensure providers receive their Complex RCM revenue so that they can focus on patient care. The Company serves clients across the United States, including half of the ten largest health systems in the country.

Read More

MEDICAL DEVICES, HEALTHCARE ANALYTICS

Stanford Spinoff PhysioWave Announces Clinical Study with Omron Healthcare

PRNewswire | May 05, 2023

PhysioWave, a spinoff from Stanford University, successfully completed a 200-subject clinical study with OMRON Healthcare Co., Ltd., a global leader in medical devices for health monitoring and treatment. PhysioWave has been developing rapid, non-invasive technology to measure a person's risk of cardiovascular disease, using a weight scale, when they arrive for a clinic visit. PhysioWave's technology is mature and FDA-cleared, and PhysioWave is seeking opportunities to bring this important new technology to the consumer space through partnerships. The PhysioWave Pro™ scale measures the stiffness of the major blood vessel into which the heart pumps, the aorta. Stiffness increases with age, but excess stiffness among people of similar ages can be a warning sign of risk. It is established that increased vascular stiffness can predict the later development of high blood pressure, or hypertension, and a higher risk of cardiovascular disease. "The chance to work with OMRON Healthcare is a true honor. We have used their blood pressure instruments as reference standards on many clinical studies and greatly value their brand power," said PhysioWave founder, Greg Kovacs, MD, PhD. The study was carried out in Kyoto, Japan, and was intended to explore the use of PhysioWave's technology to assess cardiovascular disease risk at home. This new technology could be used to monitor the beneficial effects of lifestyle changes or prescription medicines for preventing and managing cardiovascular disease. It is widely recognized that cardiovascular diseases are the leading cause of death globally, and the PhysioWave vascular stiffness technology is low-cost and requires no disposables to deliver meaningful information in under one minute. The study validated the accuracy and reproducibility of PhysioWave's vascular stiffness technology in a wide distribution of subject attributes such as age and BMI. "As we move more aggressively into disease prevention, rather than treating cardiovascular disease after it has manifested, the ability to carry out personalized cardiovascular risk assessment assumes even greater importance to our healthcare systems" said Judith Swain, MD, PhysioWave CMO, and previous Chair of Medicine at Stanford and previous Chief of Cardiovascular Medicine at the University of Pennsylvania. "OMRON Healthcare is exploring innovative technologies to help prevention and management of cardiovascular diseases for its "Going for ZERO" vision, including collaboration with partners. The accuracy of PhysioWave's vascular stiffness technology was excellent. We look forward to further exploration of cardiovascular measurement technology at home with this collaboration," said Minoru Yoshimura, Executive Officer, OMRON Healthcare Co., Ltd. PhysioWave and OMRON intend to continue to explore opportunities for vascular stiffness in consumer settings, including its use to help identify persons with a higher risk of cardiovascular disease and to provide feedback as they manage their conditions. About OMRON Healthcare Committed to advance health and empower people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision "Going for ZERO, Preventive Care for the Health of Society", the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients to reduce cerebro-cardiovascular events, aggravation of respiratory diseases and restrictions due to chronic pain. With well over 300 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions and provides products and services in over 110 countries.

Read More

More featured news